Hem Securities has come out with its report on Syrma SGS Technology. The research firm has recommended to ''Subscribe'' the ipo in its research report as on August 11, 2022.
Syrma SGS Technology IPO | Marquee investors who participated in the offer included Nomura, Eastspring Investments, Volrado Venture Partners Fund, Abakkus Emerging Opportunities Fund, Malabar Select Fund, Kuber India Fund, and Franklin India.
Geojit has come out with its report on Syrma SGS Technology. The research firm has recommended to ''Subscribe'' the ipo in its research report as on August 11, 2022.
KR Choksey has come out with its report on Syrma SGS Technology. The research firm has recommended to ''Subscribe'' the ipo in its research report as on August 11, 2022.
Syrma SGS Technology IPO | Half of the issue size is reserved for qualified institutional investors including anchor book, 15 percent of the offer for allocation to non-institutional investors and the remaining 35 percent is reserved for retail investors.
Syrma will finalise the basis of the allotment of shares by August 23 and will initiate refunds to unsuccessful investors by August 24. Equity shares will get credited to the Demat accounts of eligible investors by August 25.
In terms of volumes, Ethos traded with 26.37 lakh shares on the NSE, and 2 lakh shares on the BSE.
Ethos | The listing was on expected lines as the public issue just managed to sail through on the last day
Aether Industries IPO: The chemical company aims to raise Rs 808.04 crore through the IPO, which consists of a fresh issue of Rs 627 crore and an offer-for-sale of up to 2.82 million shares.
Aether Industries IPO: The chemicals company aims to raise Rs 808.04 crore from its public offer
Hem Securities has come out with its report on Aether Industries. The research firm has recommended to ''Subscribe'' the ipo in its research report as on May 23, 2022.
ICICI Direct has come out with its report on Aether Industries. The research firm has recommended to ''Avoid'' the ipo in its research report as on May 24, 2022.
Anand Rathi has come out with its report on Aether Industries. The research firm has recommended to ''Subscribe-Long term'' the ipo in its research report as on May 23, 2022.
eMudhra IPO: The company will use Rs 35 crore of the net proceeds to pre-pay or repay loans, while Rs 40.2 crore will be utilised to meet working capital requirements
The chemical company aims to raise Rs 808.04 crore from its public offer. Out of Rs 808.04 crore, company aims to raise Rs 627 crore through fresh issues.
Choice Equity Broking has come out with its report on Aether Industries. The research firm has recommended to ''Subscribe with Caution'' the ipo in its research report as on May 23, 2022.
Arihant Capital has come out with its report on Aether Industries. The research firm has recommended to ''Avoid'' the ipo in its research report as on May 23, 2022.
eMudhra IPO: The company had done a pre-IPO placement of 1,603,617 equity shares for a cash price of Rs 243.20 per equity share for an aggregate amount of Rs 39 crore to Baring Private Equity India AIF 2, Acacia Banyan Partners, Motilal Oswal Equity Opportunities Fund Series III, Negen Capital Services Private Limited, Value Wise Consultancy Private Limited, Jagadeesan Kumar, and Krishna Kumar.
eMudhra IPO: The company intends to utilize the net proceeds from the fresh issue to pre-pay or repay in part or full, the existing loans availed by the company to an extent of Rs 35 crore. Rs 40.2 crore will be used for funding its working capital requirements.
The company intends to garner about Rs 413 crore through fresh issue of equity shares upto Rs 161 crore and an offer for sale of of upto Rs 252 crore by the shareholders and promoters.
Choice Equity Broking has come out with its report on eMudhra. The research firm has recommended to ''Subscribe'' the ipo in its research report as on May 19, 2022.
The IPO, sized at Rs 413 crore, comprises fresh shares of Rs 161 crore and an offer for sale worth Rs 252 crore by shareholders and promoters.
The company aims to mop up Rs 1,501 crore in total from a fresh issue of shares worth Rs 1,004 crore and an offer for sale of Rs 497.73 crore
Arihant Capital has come out with its report on eMudhra. The research firm has recommended to ''Subscribe'' the ipo in its research report as on May 19, 2022.
Hem Securities has come out with its report on Paradeep Phosphates. The research firm has recommended to ''Subscribe'' the ipo in its research report as on May 17, 2022.